In two randomized controlled trials, orally administered human IgG and IgA reduced NEC incidence in preterm infants (26, 27), but a later Cochrane review concluded that there was no overall effect of oral IgG on NEC incidence in preterm infants (28). This evidence concerns the gene CD79A and necrotizing enterocolitis.